Skip to main content

PASSAGE: Effectiveness of Tezepelumab, an Injectable Medication, in Treating Severe Asthma

Research Question:
Is tezepelumab, an injectable medication, effective at treating severe asthma in adults and adolescents?

Basic Study Information

Adult and adolescent participants may be eligible if they have severe asthma with 2 or more exacerbations in the last 12 months. The study consists of 15 in-person visits (1 to 3 hours each). Visit 1 will be for eligibility screening. The study drug, tezepelumab, will be given at visits 2-14. Visit 15 will be for follow-up examination.

Study Reference #: STUDY00008180

Lead Researcher (Principal Investigator)

Lead Researcher:  Steve Georas

Study Contact Information

Study Coordinator: Marcus Dalfonso
Phone: (585) 276-7296

Additional Study Details

Number of Visits:  More than 10
Parking:  Reimbursed
Reimbursement:  Yes
Payment Details:  $60 per visit completed

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search